» Articles » PMID: 28303002

Reciprocal Regulation of γ-globin Expression by Exo-miRNAs: Relevance to γ-globin Silencing in β-thalassemia Major

Overview
Journal Sci Rep
Specialty Science
Date 2017 Mar 18
PMID 28303002
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Induction of fetal hemoglobin (HbF) is a promising strategy in the treatment of β-thalassemia major (β-TM). The present study shows that plasma exosomal miRNAs (exo-miRs) are involved in γ-globin regulation. Exosomes shuttle miRNAs and mediate cell-cell communication. MiRNAs are regulators of biological processes through post-transcriptional targeting. Compared to HD (Healthy Donor), β-TM patients showed increased levels of plasma exosomes and the majority of exosomes had cellular origin from CD34+ cells. Further, HD and β-TM exosomes showed differential miRNA expressions. Among them, deregulated miR-223-3p and miR-138-5p in β-TM exosomes and HD had specific targets for γ-globin regulator and repressor respectively. Functional studies in K562 cells showed that HD exosomes and miR-138-5p regulated γ-globin expression by targeting BCL11A. β-TM exosomes and miR-223-3p down regulated γ-globin expression through LMO2 targeting. Importantly, miR-223-3p targeting through sponge repression resulted in γ-globin activation. Further, hnRNPA1 bound to stem-loop structure of pre-miR-223 and we found that hnRNPA1 knockdown or mutagenesis at miR-223-3p stem-loop sequence resulted in less mature exo-miR-223-3p levels. Altogether, the study shows for the first time on the important clinical evidence that differentially expressed exo-miRNAs reciprocally control γ-globin expressions. Further, the hnRNPA1-exo-miR-223-LMO2 axis may be critical to γ-globin silencing in β-TM.

Citing Articles

Efficacy and safety of thalidomide in patients with β-thalassemia intermedia and major.

Ju W, Din G, Huang J, Zheng M, Wang X, Liu L Medicine (Baltimore). 2024; 103(43):e40328.

PMID: 39470504 PMC: 11521010. DOI: 10.1097/MD.0000000000040328.


Upregulation of miR‑6747‑3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in β‑thalassemia.

Lv A, Chen M, Zhang S, Zhao W, Li J, Lin S Mol Med Rep. 2024; 31(1).

PMID: 39450557 PMC: 11529187. DOI: 10.3892/mmr.2024.13372.


Construction of a prognostic model with exosome biogenesis- and release-related genes and identification of RAB27B in immune infiltration of pancreatic cancer.

Li T, Qin C, Zhao B, Li Z, Wang Y, Zhao Y Transl Cancer Res. 2024; 13(9):4846-4865.

PMID: 39430819 PMC: 11483359. DOI: 10.21037/tcr-24-54.


Potential Use of MicroRNA Technology in Thalassemia Therapy.

Rujito L, Wardana T, Siswandari W, Nainggolan I, Sasongko T J Clin Med Res. 2024; 16(9):411-422.

PMID: 39346566 PMC: 11426174. DOI: 10.14740/jocmr5245.


Transcriptional Repressor BCL11A in Erythroid Cells.

Zheng G, Orkin S Adv Exp Med Biol. 2024; 1459:199-215.

PMID: 39017845 DOI: 10.1007/978-3-031-62731-6_9.


References
1.
Habib A, Kunzelmann C, Shamseddeen W, Zobairi F, Freyssinet J, Taher A . Elevated levels of circulating procoagulant microparticles in patients with beta-thalassemia intermedia. Haematologica. 2008; 93(6):941-2. DOI: 10.3324/haematol.12460. View

2.
Klingmuller U . The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor. Eur J Biochem. 1997; 249(3):637-47. DOI: 10.1111/j.1432-1033.1997.t01-1-00637.x. View

3.
Sankaran V, Menne T, Scepanovic D, Vergilio J, Ji P, Kim J . MicroRNA-15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci U S A. 2011; 108(4):1519-24. PMC: 3029749. DOI: 10.1073/pnas.1018384108. View

4.
Kittikalayawong Y, Sila-Asna M, Bunyaratvej A . Enhanced maturation and proliferation of beta-thalassemia/Hb E erythroid precursor cells in culture. Southeast Asian J Trop Med Public Health. 2006; 36(5):1298-303. View

5.
Sankaran V, Xu J, Ragoczy T, Ippolito G, Walkley C, Maika S . Developmental and species-divergent globin switching are driven by BCL11A. Nature. 2009; 460(7259):1093-7. PMC: 3749913. DOI: 10.1038/nature08243. View